NSEPress Release30 Sept 2026 · 30 Sept 2026, 05:57 pm
Press Release
Avio Smart Market Stack Limited · ASMS
✦ AI Summary▲ PositiveExpansion
Avio Smart Market Stack Limited has partnered with Huwel Lifesciences to expand access to compact RT-PCR testing across India, establishing a dedicated sales and distribution infrastructure.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Avio Smart Market Stack Limited has informed the Exchange regarding a press release dated September 30, 2026, titled "ASMS and Huwel Lifesciences Join Hands to Expand Access to Compact RT-PCR Testing Across India".
Attachments (1)
📄pdf
Download →
BARTRONICS1_30092026175703_Press_release_dated_30september.pdf
View document text
Date: 30.09.2026
To, To,
BSE Limited, National Stock exchange of India Limited,
Listing Department, P.J. Towers, Dalal Exchange Plaza, C-1, Block G,
Street, Mumbai – 400 001 Bandra Kurla Complex, Bandra (E)
Scrip Code: 532694 Mumbai – 400 051
Symbol: ASMS
Dear Sir/Madam,
Sub: Intimation regarding Press Release under Regulation 30 of SEBI (LODR)
Regulations, 2015
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, please find enclosed a copy of the Press Release being issued by the
Company today titled:
“ASMS and Huwel Lifesciences Join Hands to Expand Access to Compact RT-PCR Testing
Across India”.
A copy of the said Press Release is enclosed herewith as Annexure – I.
You are requested to kindly take the above information on record.
Yours faithfully,
For Avio Smart Market Stack Limited
(Formerly Known as Bartronics India Limited)
Diksha Omer
Company Secretary
ANNEXURE-I
ASMS and Huwel Lifesciences Join Hands to Expand Access to
Compact RT-PCR Testing Across India
National, 30th September 2026:
Avio Smart Market Stack Limited (ASMS), (formerly known as Bartronics India Limited),
and Huwel Lifesciences are strengthening their collaboration to build a nationwide
commercialisation platform for Cubo, Huwel’s ultra-compact RT-PCR system. The initiative
aims to expand access to molecular diagnostics across India’s private healthcare sector,
including hospitals, diagnostic centres, research institutions and smaller healthcare facilities.
As part of the collaboration, the two companies plan to establish a dedicated sales and
distribution infrastructure, including the recruitment of senior sales leadership, formation of
specialised sales teams and development of strategic channel partnerships. The initiative will
initially focus on Cubo while creating opportunities to commercialise Huwel’s broader
molecular diagnostics portfolio.
Commenting on the collaboration, N Vidhya Sagar Reddy, Managing Director, ASMS,
said, “The next phase of our collaboration with Huwel is focused on building the commercial
infrastructure needed to take advanced molecular diagnostic technologies to a much wider
customer base. Cubo’s compact format creates an opportunity to bring RT-PCR capabilities
closer to hospitals, laboratories and other healthcare providers, including those outside the
traditional centralised laboratory ecosystem. Our focus will be on building the sales
leadership, distribution network and market coverage required to support its adoption at scale
across India.”
Cubo is designed to enable RT-PCR testing beyond conventional centralised laboratory
environments. Its ultra-compact design allows molecular diagnostic capabilities to be
considered for smaller and more decentralised healthcare settings, potentially reducing
dependence on large centralised facilities. This is particularly relevant to India’s healthcare
landscape, which spans metropolitan centres as well as a large and geographically distributed
network of Tier-II and Tier-III cities, hospitals and diagnostic facilities.
The commercialisation strategy will focus on private hospitals, diagnostic chains,
independent laboratories, medical colleges, research institutions and other healthcare
establishments. The proposed sales organisation will work across direct sales and channel
partnerships, supported by product demonstrations, installation support and ongoing customer
engagement.
Beyond instrument deployment, ASMS and Huwel intend to develop an ecosystem around
the platform, comprising compatible molecular assays and consumables that can support
recurring testing requirements. Huwel’s capabilities across molecular diagnostic applications
could enable Cubo installations to serve multiple testing needs rather than being limited to a
single application.
The collaboration marks the next phase of the relationship between ASMS and Huwel, with
the focus now expanding from product and institutional opportunities towards building a
broader commercial engine for Huwel’s molecular diagnostics portfolio. For ASMS, the
initiative represents an opportunity to build its presence in healthcare and diagnostics through
indigenous technologies, while Huwel gains additional commercial reach and execution
capabilities to support the wider adoption of its products.
Through the planned sales leadership, distribution partnerships and nationwide market
coverage, the companies aim to create a scalable commercial platform that can take compact
molecular diagnostic capabilities to a broader universe of healthcare providers across India.
About Avio Smart Market Stack Limited
Avio Smart Market Stack Limited (ASMS) is a diversified platform company focused on building scalable businesses across
Financial Inclusion & Digital Services, Agri Supply Chain & Technologies, and Diagnostics & Healthcare. Through its
Financial Inclusion division, the Company has established a strong presence across rural India, creating a trusted distribution
network. Building on this foundation, ASMS is developing a technology-enabled agri ecosystem while leveraging its
existing reach. The Company has also entered into a strategic partnership with a cutting-edge molecular diagnostics
company to diversify into the high-growth healthcare and diagnostics sector.